Ascentage Pharma Group International (OTCPK:ASPHF)
$ 4.53 -0.17 (-3.51%) Market Cap: 1.51 Bil Enterprise Value: 1.44 Bil PE Ratio: 0 PB Ratio: 7.96 GF Score: 71/100

Full Year 2025 Ascentage Pharma Group International Earnings Presentation Transcript

Mar 26, 2026 / 12:00PM GMT
Release Date Price: $8.48

Mar 26, 2026 / 12:00PM GMT
Presentation
Mar 26, 2026 / 12:00PM GMT

=====================
Corporate Participants
=====================
* Yuly Chen
Ascentage Pharma Group International - Senior Director of Investor Relations
* Dajun Yang
Ascentage Pharma Group International - Executive Chairman of the Board, Chief Executive Officer, Co-Founder
* Veet Misra
Ascentage Pharma Group International - Chief Financial Officer
* Zhichao Si
Ascentage Pharma Group International - Head of Commercial

=====================
Conference Call Participants
=====================
* Brian Cheng
JPMorgan Chase & Co - Analyst
* Biren Amin
Piper Sandler - Analyst
* Supawat Thongthip
Truist Securities - Analyst
* Jeet Mukherjee
BTIG LLC - Equity Analyst
* Matthew Biegler
Oppenheimer & Co Inc - Analyst
* Christopher Liu
Lucid Capital Markets LLC - Analyst
* Michael King
Rodman & Renshaw - Analyst

=====================
Operator<

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot